Posts by Follicle Thought
WAY-316606 Product Release Update 2020
In this article I have a brief update to share regarding the anticipated release of a product based on the WAY-316606 research by Giuliani Pharma. After a long break in communication I’ve received some updated information regarding the development of a WAY-316606 analog product from Dr. Barbara Marzani, Project Manager of Research & Development at…
Read MoreUpdate On Dr. Tsuji’s Hair Multiplication Trial In 2020
Hair Growth Compounds In Development – Update (8/30/20) As mentioned in the original article, Dr. Tsuji also made an online presentation for the Adva Corporation on August 25, 2020. I attempted to attend the lecture but it seemed that residents outside of Japan were not permitted to join the Zoom conference. Luckily, our jovial Youtuber…
Read MoreStemore Updated Website & Therapies
Stemore of Korea has recently updated their website with exciting new information. Asia’s #1 Hair Loss Cure Research Company I remember reading that Stemore hoped to one day become Asia’s leading company in the field of hair loss cure research and development. I think after reading this article you may agree that they have already…
Read MoreKoehler Lab Seeks Partners For Hair Cloning Technology
Koehler Lab Identifies Partner To Move Technology Forward: Update (7/7/21) About one year after this article was originally published, I have received a noteworthy update to share from Dr. Karl Koehler. Most importantly, as you read in the heading, an undisclosed company has stepped up to the plate to further Koehler’s research towards the clinic.…
Read MoreFollica Announces Phase 3 Trial Design In 2020
We have yet another company moving towards a pivotal trial for hair regrowth in 2020. On June 4, 2020, Follica issued a press release to announce a positive ‘end of phase 2 meeting’ with the US FDA in preparation to begin a phase 3 trial this year. The release also outlines details of Follica’s phase…
Read MoreKintor Pharmaceuticals Furthers Baldness Treatment Drugs In US And China
US Male Phase 2 Pyrilutamide Trial Underway: Update (3/1/22) Consistent progress is the M.O. of Kintor Pharma. On March 1, 2022 it was announced that the first patients in a US phase 2 trial for males have received dosing. The four cohorts in the trial will receive topical dosing of either 2.5 mg pyrilutamide twice…
Read MoreRecruitment Information For HST 001 Hair Growth Trial In 2020
Update (6/22/20) The Manager of Recruitment at the California Dermatology & Clinical Research Institute reached out to me over the weekend to let me know that their site is still seeking participants for the HST-001 trial. Recruitment for the trial is scheduled to close in about 3 weeks so if you live in the San…
Read MoreHairClone Timeline Update May 2020
Today, HairClone sent out its latest newsletter and first official update of 2020. Newsletter May 2020 Here are the important bullet points from HairClone’s latest newsletter including an invitation to complete a survey for the company: Business News In Oct 2019, we were successful in winning a significant 15 month grant from the UK Government…
Read MoreHistogen Announces HSC Trial Plans In 2020
Histogen Doses First Patient In 1B/2A Trial – Update 6/2/20 Histogen has wasted no time in getting their latest trial of HST-001 (HSC) underway. On June 1, 2020, the company sent out a press release to announce the first male patient has been dosed in their latest trial of HSC. Positive developments seem to be…
Read MoreNew Company: Triple Hair
Follicle Thought is pleased to present an exclusive look at a newcomer in the hair loss treatment industry, Triple Hair of Canada. Triple Hair’s Story Triple Hair was founded by Dr. Houfar Sekhavat, an opthalmologist based in Moncton, Canada. It was Dr. Sekhavat’s own experience with androgenic alopecia which lead him to seek out a…
Read More